TTT-Introduction in Milan

This week Cybion introduced the Transerse Tibia Transport (TTT)-Treatment to the Diabetic Foot Unit at the IRCCS Multimedica Hospital, Milan, Italy.
Dr. Enrico Brocco,Director of Interhospital Diabetology/Diabetic foot Unit, who did the first TTT-cases in Europe, explained his team the outstanding possibilities with this unique treatment in “no option patients” in order to avoid major amputations.

Prof. Carlo MF Caravaggi MD, who is doing groundbreaking research in the treatment of Diabetic patients, was also present and explained the mechanism and effects generated by the stimulation with the TTT-Treatment.

Cybion is looking very forward to start very soon in treating these patients in this famous Hospital in Milan. 
We also want to thank Biomedica Italia Srl, our business partner in Italy for their support.​